Anne Mäkipernaa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Anne Mäkipernaa has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
S. Ranta
Children’s Hospital, Helsinki University Central Hospital, Helsinki, Finland
4 shared publicationsA. Wikström
Children′s Hospital and Helsinki University Central Hospital Helsinki Finland
1 shared publication- Anne Pitkäranta
Department of Otorhinolaryngology, Helsinki University Central Hospital, Helsinki, Finland
1 shared publication B. Verbruggen
Radboud University Nijmegen Medical Centre Nijmegen The Netherlands
1 shared publicationH. Alapulli
Department of Oral and Maxillofacial Diseases, Helsinki University Central Hospital, Helsinki, Finland
1 shared publicationH. Rajantie
Institute of Dentistry, University of Helsinki, Helsinki, Finland
1 shared publication
Latest Publications
- Open Access
Venous Malformations and Blood Coagulation in Children
Introduction: Venous malformations (VMs) are congenital low-flow lesions with a wide spectrum of clinical manifestations. An increasing number of studies link VMs to coagulation abnormalities, especially to elevated D-dimer and decreased fibrinogen. This condition, termed localized intravascular coagulopathy (LIC), may pose a risk for hemostatic complications. However, detailed data on the laboratory variables for coagulation and fibrinolytic activity in VM patients are limited. We addressed this question by systematically analyzing the coagulation parameters in pediatric VM patients. Methods: We included 62 patients (median age 11.9 years) with detailed laboratory tests for coagulation and fibrinolytic activity at a clinically steady phase. We assessed clinical and imaging features of VMs and their correlations with coagulation and fibrinolysis variables using patient records and MRI. Results: D-dimer was elevated in 39% and FXIII decreased in 20% of the patients, as a sign of LIC. Elevated D-dimer and decreased FXIII were associated with large size, deep location, and diffuse and multifocal VMs. FVIII was elevated in 17% of the patients and was associated with small VM size, superficial and confined location, discrete morphology, and less pain. Surprisingly, antithrombin was elevated in 55% of the patients but without associations with clinical or other laboratory variables. Conclusions: LIC was common in pediatric patients with VMs. Our results provide a basis for when evaluating the risks of hemostatic complications in children with VMs. Further research is warranted to explore the mechanisms behind coagulation disturbances and their relation to clinical complications.
Open AccessVenous Malformations and Blood Coagulation in Children
Introduction: Venous malformations (VMs) are congenital low-flow lesions with a wide spectrum of clinical manifestations. An increasing number of studies link VMs to coagulation abnormalities, especially to elevated D-dimer and decreased fibrinogen. This condition, termed localized intravascular coagulopathy (LIC), may pose a risk for hemostatic complications. However, detailed data on the laboratory variables for coagulation and fibrinolytic activity in VM patients are limited. We addressed this question by systematically analyzing the coagulation parameters in pediatric VM patients. Methods: We included 62 patients (median age 11.9 years) with detailed laboratory tests for coagulation and fibrinolytic activity at a clinically steady phase. We assessed clinical and imaging features of VMs and their correlations with coagulation and fibrinolysis variables using patient records and MRI. Results: D-dimer was elevated in 39% and FXIII decreased in 20% of the patients, as a sign of LIC. Elevated D-dimer and decreased FXIII were associated with large size, deep location, and diffuse and multifocal VMs. FVIII was elevated in 17% of the patients and was associated with small VM size, superficial and confined location, discrete morphology, and less pain. Surprisingly, antithrombin was elevated in 55% of the patients but without associations with clinical or other laboratory variables. Conclusions: LIC was common in pediatric patients with VMs. Our results provide a basis for when evaluating the risks of hemostatic complications in children with VMs. Further research is warranted to explore the mechanisms behind coagulation disturbances and their relation to clinical complications.
- 26 September 2013
- Published by Springer Nature in European Archives of Paediatric Dentistry
- Vol. 14 (5) , 339-343
Oral health care in children with haemophilia in Helsinki, Finland
Background The bleeding tendency and fear of bleeds may have a negative effect on preventive dental care of patients with haemophilia both at home and at dental appointments. Aim To describe the clinical practice of dental care in children with haemophilia in Helsinki, Finland. Methods This study evaluated retrospectively the medical records of 28 paediatric patients with haemophilia (aged 5.3–17.4 years) from dental visits during 2009–2010. Decayed, missing and filled teeth in the primary (dmft) and permanent dentition (DMFT), Community Periodontal Index (CPI), signs of developmental dental defects in enamel and the number of preventive and restorative procedures were gathered. Dmft + DMFT scores were compared with those of 17,079 non-haemophiliac boys. The Mann–Whitney U-test was used to compare the data between the groups of different severity of haemophilia. Results The median number of dental visits per patient was three (range 1–11). Twenty-two patients (79 %) had dmft + DMFT-scores within the 95 % reference range for age. None of the children had a CPI >2. Twelve (43 %) patients had developmental enamel defects. Half had received restorative dental care and three out of four preventive procedures. Conclusions Dental care during hospital visits in children with haemophilia may enhance confidence in the preventive dental care and help minimise bleeding during dental procedures.
- 26 September 2013
- Published by Springer Nature in European Archives of Paediatric Dentistry
- Vol. 14 (5) , 339-343
Oral health care in children with haemophilia in Helsinki, Finland
Background The bleeding tendency and fear of bleeds may have a negative effect on preventive dental care of patients with haemophilia both at home and at dental appointments. Aim To describe the clinical practice of dental care in children with haemophilia in Helsinki, Finland. Methods This study evaluated retrospectively the medical records of 28 paediatric patients with haemophilia (aged 5.3–17.4 years) from dental visits during 2009–2010. Decayed, missing and filled teeth in the primary (dmft) and permanent dentition (DMFT), Community Periodontal Index (CPI), signs of developmental dental defects in enamel and the number of preventive and restorative procedures were gathered. Dmft + DMFT scores were compared with those of 17,079 non-haemophiliac boys. The Mann–Whitney U-test was used to compare the data between the groups of different severity of haemophilia. Results The median number of dental visits per patient was three (range 1–11). Twenty-two patients (79 %) had dmft + DMFT-scores within the 95 % reference range for age. None of the children had a CPI >2. Twelve (43 %) patients had developmental enamel defects. Half had received restorative dental care and three out of four preventive procedures. Conclusions Dental care during hospital visits in children with haemophilia may enhance confidence in the preventive dental care and help minimise bleeding during dental procedures.
- 28 May 2012
- Published by Wiley in Haemophilia
- Vol. 18 (4) , e349-e351
Identical but different: haemophilia B in monozygotic twins with inhibitor in one brother and subsequent successful immune tolerance induction
- 28 May 2012
- Published by Wiley in Haemophilia
- Vol. 18 (4) , e349-e351
Identical but different: haemophilia B in monozygotic twins with inhibitor in one brother and subsequent successful immune tolerance induction
- 19 December 2011
- Published by Wiley in Haemophilia
- Vol. 18 (4) , 521-526
MRI after removal of central venous access device reveals a high number of asymptomatic thromboses in children with haemophilia
Summary. Central venous access devices (CVADs) are often required in children with haemophilia to secure venous access for prophylactic treatment or immune tolerance therapy. Complications of CVADs include infections, thrombosis and mechanical problems. This study sought to determine the outcome of the vessels by magnetic resonance imaging (MRI) in children with haemophilia and to assess risk factors for development of catheter-related deep venous thrombosis (DVT). After the removal of CVAD an MRI of the chest and neck was performed to 20 boys with haemophilia who each had 1–3 (total number 27) CVADs placed. MRI revealed DVT in five children (25%). As their CVADs were functional at the time of the removal, the DVTs were clinically silent. However, there had been suspicion of DVT leading to replacement of the CVAD in one case. All the children with DVT had their CVADs inserted initially below the age of 1 year. The clinical signs of mild post-thrombotic syndrome (PTS) were common: dilated chest wall veins were observed in 11 (55%) children and were associated with DVT in three cases. Arm circumference discrepancy was observed in one child with DVT. No correlation between the duration or number of CVADs and DVT was detected. None of the patients had subjective symptoms of PTS. Silent DVT is a common complication of CVAD. Catheter insertion at a young age seems to predispose to thrombosis. The long-term consequences of the DVTs remain unknown.
- 19 December 2011
- Published by Wiley in Haemophilia
- Vol. 18 (4) , 521-526
MRI after removal of central venous access device reveals a high number of asymptomatic thromboses in children with haemophilia
Summary. Central venous access devices (CVADs) are often required in children with haemophilia to secure venous access for prophylactic treatment or immune tolerance therapy. Complications of CVADs include infections, thrombosis and mechanical problems. This study sought to determine the outcome of the vessels by magnetic resonance imaging (MRI) in children with haemophilia and to assess risk factors for development of catheter-related deep venous thrombosis (DVT). After the removal of CVAD an MRI of the chest and neck was performed to 20 boys with haemophilia who each had 1–3 (total number 27) CVADs placed. MRI revealed DVT in five children (25%). As their CVADs were functional at the time of the removal, the DVTs were clinically silent. However, there had been suspicion of DVT leading to replacement of the CVAD in one case. All the children with DVT had their CVADs inserted initially below the age of 1 year. The clinical signs of mild post-thrombotic syndrome (PTS) were common: dilated chest wall veins were observed in 11 (55%) children and were associated with DVT in three cases. Arm circumference discrepancy was observed in one child with DVT. No correlation between the duration or number of CVADs and DVT was detected. None of the patients had subjective symptoms of PTS. Silent DVT is a common complication of CVAD. Catheter insertion at a young age seems to predispose to thrombosis. The long-term consequences of the DVTs remain unknown.
- 30 May 2011
- Published by Wiley in Haemophilia
- Vol. 17 (5) , e833-e834
Successful eradication of inhibitor of late recurrence and other high risk prognostic factors in a patient with severe haemophilia A
- 30 May 2011
- Published by Wiley in Haemophilia
- Vol. 17 (5) , e833-e834
Successful eradication of inhibitor of late recurrence and other high risk prognostic factors in a patient with severe haemophilia A
- 1 May 2008
- Published by Wiley in Haemophilia
- Vol. 14 (3) , 612-614
Fifteen years of population based experience in Finland with a plasma-derived monoclonal purified factor VIII concentrate
- 1 May 2008
- Published by Wiley in Haemophilia
- Vol. 14 (3) , 612-614
Fifteen years of population based experience in Finland with a plasma-derived monoclonal purified factor VIII concentrate